We improve patient lives by unlocking the tissue phenome.

In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer.

Definiens' Tissue Phenomics approach was awarded the 2013 Frost and Sullivan Company of the Year Award for Global Tissue Diagnostics and Pathology Imaging. For more information, please visit: www.definiens.com.

Do you want to share our pioneering vision and be part of this significant approach?

Current Job Openings at Definiens

HR

IT

Manager IT Support Services (m/f)
Definiens AG Munich

Medical

Staff Pathologist (m/f)
Definiens AG Munich

Product Development

Validation Manager (m/f)
Definiens AG Munich

Professional Services

Project Manager
Definiens Inc. Boston

Quality and Regulatory

Regulatory Affairs Expert (m/f)
Definiens AG Munich

Software Operations

Technical Support Engineer (m/f)
Definiens AG Munich
Share this page: